Prescription price controls and importing inferior medications will hurt both patients and America’s standards. We should ...

Every day, more people are waking up feeling overwhelmed by anxiety or weighed down by depression. In a world that moves fast ...

The Food and Drug Administration (FDA) can maintain its high bar for safety and efficacy, and also cut the waste and ...

Technology will soon make it possible to develop cheap, widely accessible psychoactive substances that are not harmful in the ...

A new cancer drug candidate has demonstrated the ability to block tumor growth without triggering a common and debilitating side effect.

It was another athlete, however, who had come to make a splash that day. Retired Australian swimming star James Magnussen—a former world champion who won three Olympic medals—had said publicly ...

To make sure patients keep using its drugs, clinicians say, Horizon staffers negotiate with insurance carriers, and the company offers drug discounts to lower-income patients while swaddling them ...

A new memoir, "Unshrunk," offers a scathing critique of the psychiatric drug industry, and forges a new path to healing.

Adam Colborn, JD, of AMCP, discusses the complexities of drug pricing and what policymakers must consider in efforts to reduce prices and increase access.

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.